- 301. amino 3 hydroxy 5 methylisoxazole 4 propionate
- [An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. ( MSH )] (UMLS (CSP) C0051318) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 351. Aminosugars Metabolism
- [The chemical reactions and pathways involving any amino sugar, sugars containing an amino group in place of a hydroxyl group. [GOC:jl, ISBN:0192801023] ( GO )] (UMLS (NCI) C1156862) Aminosugars Metabolism Pathway;
=Molecular Function |
- 302. Amino Acid Biosynthesis
- [anabolic formation of aminoacids in organisms or living cells and cell extracts. ( CSP )] (UMLS (NCI) C0596074) =Molecular Function ;
=anabolism;
aminoacid metabolism | - 352. aminosulfonate
- [ ] (UMLS (CSP) C0596081) =Inorganic Chemical ;
|
- 303. Amino Acid Channel
- [Amino Acid Transporter proteins carry organic compounds containing an amino (-NH2) and a carboxyl (-COOH) group through solubility barriers, such as aqueous body fluids, lipid membranes or across epithelial layers. After binding substrate, transmembrane transporters often undergo an energy-dependent conformational change that moves the substrate across the membrane with (symport) or against (antiport) concentration gradients. ( NCI )] (UMLS (NCI) C0949771) Amino Acid Transporter;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 353. aminothiol
- [organic compound similar to an alcohol but in which the oxygen atom has been replaced by a sulfur atom and to which an amino group is attached. ( CSP )] (UMLS (CSP) C0596082) =Organic Chemical ;
=amine;
mercaptan =cysteamine;
|
- 304. Amino Acid Injection
- [A type of nutritional support. It is particularly useful when oral nutrition is unfeasible, impractical or inadequate. ( NCI )] (UMLS (NCI) C0280081) =Clinical Drug
| - 354. aminotransferase
- [Transaminases are a sub-subclass of mostly pyridoxal phosphate-dependent transferase enzymes that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Mediating conversion of major intermediate metabolites and reversible transamination, Transaminases are often involved in cellular nitrogen metabolism, amino acid metabolism, gluconeogenesis and in the urea and tricarboxylic acid cycles. ( NCI )] (UMLS (CSP) C0002594) =Amino Acid, Peptide, or Protein; Enzyme
|
- 305. Amino Acid Metabolism - Reference Pathway
- (UMLS (NCI) C1510864) Amino Acid Metabolism Pathway;
=Molecular Function ;
| - 355. amiodarone
- [2-butyl-3-(3,5-diiodo-4-beta diethylaminoethoxybenzoyl) benzofuran; coronary vasodilator used as an antiarrhythmic; severe risk of pulmonary and hepatic toxicity via disruption of lysosomal function; also has amphiphilic phototoxin properties. ( CSP )] (UMLS (CSP) C0002598) =Organic Chemical; Pharmacologic Substance
|
- 306. Amino Acid Receptor Binding
- [Amino Acid Receptor Interaction involves non-covalent binding through intermolecular physical forces of attraction with a group of intrinsic membrane proteins that bind to and mediate the biological effects of small organic compounds containing an amino and carboxyl group that act as neurotransmitters (e.g., glutamic acid or aspartic acid) through modification of the activity of signal transduction pathways in target cells. ( NCI )] (UMLS (NCI) C1510865) =Molecular Function ;
| - 356. amiodarone/DOX
- (UMLS (NCI) C0279280) =Therapeutic or Preventive Procedure ;
|
- 307. amino acid sequence
- [order of amino acids as they occur in a polypeptide chain. ( CSP )] (UMLS (NCI) C0002518) =Amino Acid Sequence
| - 357. amiodarone/DOX/VP-16
- (UMLS (NCI) C0279279) =Therapeutic or Preventive Procedure ;
|
- 308. Amino Acid Synthesis Inhibition
- [Amino Acid Synthesis Inhibition involves interference with, or restraint of, enzymatic formation of organic compounds that contain an amino (-NH2) and a carboxyl (-COOH) group. ( NCI )] (UMLS (NCI) C1510866) =Physiologic Function ;
| - 358. Amiodarone/VBL
- (UMLS (NCI) C0280651) =Therapeutic or Preventive Procedure
|
- 309. Amino Acid, Peptide, or Protein
- [Amino acids and chains of amino acids connected by peptide linkages. ( NCI )] (UMLS (NCI) C1254349) =Amino Acid, Peptide, or Protein ;
| - 359. Amish
- [ ] (UMLS (CSP) C0238622) =Population Group
|
- 310. amino group
- [monovalent chemical group -NH2. ( CSP )] (UMLS (CSP) C0596072) =Inorganic Chemical ;
=chemical group;
| - 360. amitosis
- [Nuclear division that occurs by simple constriction of the nucleus without chromosome condensation or spindle formation. [http://cancerweb.ncl.ac.uk/, ISBN:0721662544] ( GO )] (UMLS (CSP) C0598083) =Cell Function ;
|
- 311. AMINO-ACID TRANSPORT DIS
- (UMLS (ICD9CM) C0268641) =Disease or Syndrome
| - 361. amitriptyline
- [tricyclic antidepressant with anticholinergic and sedative properties; it appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters; it also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. ( CSP )] (UMLS (CSP) C0002600) =Organic Chemical; Pharmacologic Substance
|
- 312. Amino-Arginine
- [An amino acid derivative. As an analog of arginine, amino-arginine competes with the normal substrate arginine and binds to the heme of the NOS as a false substrate, thereby inhibiting endothelial and inducible nitric oxide synthases (eNOS / NOS III and iNOS / NOS II). Arginine is the only physiological substrate for NOS which, in eukaryotic cells, generates NO and L-citrulline from L-arginine and molecular oxygen in a five-electron transfer reaction. This clinical use of amino-arginine is limited due to its epileptogenic properties. (NCI04) ( NCI )] (UMLS (NCI) C1510863) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 362. AMLODIPINE
- [A synthetic dihydropyridine and a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine inhibits the influx of extracellular calcium ions into myocardial and peripheral vascular smooth muscle cells, thereby preventing vascular and myocardial contraction. This results in a dilatation of the main coronary and systemic arteries, decreases myocardial contractility, increases blood flow and oxygen delivery to the myocardial tissue and decreases total peripheral resistance. This agent may also modulate multi-drug response (MDR) activity through inhibition of the p-glycoprotein efflux pump. ( NCI )] (UMLS (NCI) C0051696) =Organic Chemical; Pharmacologic Substance =antihypertensive agent;
[CV200] CALCIUM CHANNEL BLOCKERS;
Dihydropyridines;
[CV250] ANTIANGINALS =AMLODIPINE BESYLATE |
- 313. aminoacid analog
- [synthetic or natural compounds which resemble naturally occurring amino acids in structure and/or function. ( CSP )] (UMLS (CSP) C0178472) =Amino Acid, Peptide, or Protein =analog;
=biocytin;
phenylalanine analog;
tryptophan analog;
tyrosine analog | - 363. Amlodipine Besylate/Benazepril Hydrochloride
- [Having a substantial blood pressure lowering capability, Amlodipine Besylate Benazepril Hydrochloride contains a dihydropyridine calcium blocker (amlodipine) and an angiotensin-converting enzyme (ACE) inhibitor (benazepril). A long-acting calcium channel antagonist, Amlodipine inhibits transmembrane calcium influx into vascular smooth muscle. Blocking ACE, Benazepril decreases vasopressive plasma angiotensin II. (NCI04) ( NCI )] (UMLS (NCI) C1302063) =Organic Chemical; Pharmacologic Substance ;
|
- 314. aminoacid analyzer
- [biomedical equipment or process used to determine the quantities of each individual amino acid in a protein. ( CSP )] (UMLS (CSP) C0179025) =Medical Device =Medical Devices;
| - 364. AMLODIPINE MALEATE
- [The maleate salt of amlodipine, a synthetic phenylpyridine vasodilator with antihypertensive and antianginal effects. Amlodipine inhibits the influx of extracellular calcium ions into myocardial and peripheral vascular smooth muscle cells, thereby preventing vascular and myocardial contraction. Furthermore, decreased myocardial contractility and dilation of the main coronary and systemic arteries lead to increased blood flow and oxygen delivery to the myocardial tissue and decreases total peripheral resistance. This agent may also modulate multi-drug response activity through inhibition of the p-glycoprotein efflux pump. ( NCI )] (UMLS (NCI) C0886700) =Organic Chemical; Pharmacologic Substance ;
|
- 315. aminoacid inhibitor
- [any substance or state which suppresses, prevents, or opposes the action of aminoacids. ( CSP )] (UMLS (CSP) C0596075) =Pharmacologic Substance ;
=inhibitor/antagonist;
| - 365. Ammon's horn
- [a layer of gray matter lying along the floor of the lateral ventricle of the brain, comprised of cholinergic and possibly glutamatergic fibers, believed to be the critical brain structure underlying learning and memory. ( CSP )] (UMLS (CSP) C0019564) =Body Part, Organ, or Organ Component ;
=limbic system;
=dentate gyrus |
- 316. aminoacid metabolism
- [buildup and breakdown of aminoacids for utilization by the organism. ( CSP )] (UMLS (CSP) C0596076) =Molecular Function ;
=Intermediary Metabolism;
=Amino Acid Biosynthesis;
urea cycle | - 366. ammonia
- [colorless alkaline gas formed in the body during decomposition of organic materials during a large number of metabolically important reactions. ( CSP )] (UMLS (CSP) C0002607) =Biologically Active Substance; Inorganic Chemical
|
- 317. aminoacid oxidase
- [ ] (UMLS (CSP) C0596077) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
| - 367. ammonia lyase
- [Enzymes that catalyze the formation of a carbon-carbon double bond by the elimination of AMMONIA. EC 4.3.1. ( MSH )] (UMLS (CSP) C0002610) =Amino Acid, Peptide, or Protein; Enzyme
|
- 318. aminoacid sequence of peptide
- [ ] (UMLS (CSP) C0920679) aminoacid sequence of protein;
peptide sequence =Amino Acid Sequence ;
| - 368. ammonia poisoning
- [ ] (UMLS (CSP) C0597829) =Injury or Poisoning
|
- 319. aminoacid transport
- [movement of aminoacids through a biological system at the cellular level; can be across cell membranes and epithelial layers and also can occur within intracellular compartments and extracellular compartments. ( CSP )] (UMLS (CSP) C0596078) =Cell Function ;
=biological transport;
| - 369. Ammonium 5-Tungsto-2-antimonate
- (UMLS (NCI) C0103100) =Pharmacologic Substance; Inorganic Chemical
|
- 320. aminoacid tRNA ligase
- [A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS. ( MSH )] (UMLS (CSP) C0002529) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 370. ammonium compound
- [inorganic and organic compounds that contain the radical NH4 or ammonium. ( CSP )] (UMLS (CSP) C0002616) =Chemical Viewed Structurally ;
|
- 321. aminoacyl fatty acid
- [ ] (UMLS (CSP) C0598431) =Lipid ;
| - 371. Ammonium heparin
- (UMLS (HL7) C1550071) =Organic Chemical; Biomedical or Dental Material ;
=Additive/Preservative;
|
- 322. aminoacyl nucleotide
- [ ] (UMLS (CSP) C0598999) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 372. Ammonium heparin
- [Ammonium heparin ( HL7V3.0 )] (UMLS (HL7) C1561472) =Intellectual Product =MaterialEntityAdditive;
|
- 323. aminoacyl tRNA
- [intermediates in protein biosynthesis; the compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase; they are key compounds in the genetic translation process. ( CSP )] (UMLS (CSP) C0035714) =Nucleic Acid, Nucleoside, or Nucleotide; Amino Acid, Peptide, or Protein; Biologically Active Substance =transfer RNA;
| - 373. Ammonium N-hydroxy-N-nitrosobenzenamine
- [A creamy, white crystalline substance. Cupferron is used as an analytical reagent to separate copper, iron and vanadium from other metals. Exposure to this substance causes gastrointestinal disturbances and skin, eye and respiratory-tract irritation. Cupferron is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05) ( NCI )] (UMLS (NCI) C0056590) =Organic Chemical
|
- 324. Aminoacyl-tRNA Biosynthesis
- (UMLS (NCI) C1510867) Aminoacyl-tRNA Biosynthesis Pathway;
=Conceptual Entity ;
| - 374. Ammunition
- [A complete device charged with explosives, propellants, pyrotechnics, initiating composition, or nuclear, biological, or chemical material for use in military operations, including demolitions. ( NCI )] (UMLS (NCI) C0336683) =Manufactured Object
|
- 325. aminoacyltransferase
- [Enzymes that catalyze the transfer of an aminoacyl group from donor to acceptor resulting in the formation of an ester or amide linkage. EC 2.3.2. ( MSH )] (UMLS (CSP) C0524998) =Amino Acid, Peptide, or Protein; Enzyme =Acetyltransferase;
=glutamyltransferase;
| - 375. AMN
- [A synthetic or natural carcinogenic compound found in a variety of smokes and industrial products, N-Amyl-N-Methylnitrosoamine is used in biomedical research to induce experimental hepatocarcinogenesis, probably through abnormal DNA methylation. (NCI04) ( NCI )] (UMLS (NCI) C0067813) =Organic Chemical; Hazardous or Poisonous Substance
|
- 326. aminoazobenzene
- [ ] (UMLS (CSP) C0178473) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 376. amnesia
- [Systematic and extensive loss of memory caused by organic or psychological factors. The loss may be temporary or permanent, and may involve old or recent memories. ( NCI )] (UMLS (CSP) C0002622) =Mental or Behavioral Dysfunction ;
|
- 327. aminobenzene
- [compounds containing a benzene ring and an amine group. ( CSP )] (UMLS (CSP) C0003036) =Organic Chemical; Hazardous or Poisonous Substance
| - 377. AMNESTIC DISORD OTH DIS
- (UMLS (ICD9CM) C0002625) =Mental or Behavioral Dysfunction ;
|
- 328. Aminobenzoate Potassium
- [The potassium salt form of aminobenzoate, with anti-inflammatory and antifibrotic activities. Aminobenzoate potassium increases oxygen uptake at the tissue level and may enhance monoamine oxidase (MAO) activity, which requires oxygen as a substrate. Enhanced MAO activity maybe accountable for the prevention or regression of fibrosis, which may occur due to too much serotonin or too little MAO activity. ( NCI )] (UMLS (NCI) C0543464) =Organic Chemical; Pharmacologic Substance =[DE890] DERMATOLOGICALS, SYSTEMIC OTHER;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=POTASSIUM PARA-AMINOBENZOATE 100 GM;
POTASSIUM PARA-AMINOBENZOATE 0.5 GM;
POTASSIUM PARA-AMINOBENZOATE 0.3 GM;
POTASSIUM PARA-AMINOBENZOATE 2 GM;
| - 378. amniocentesis
- [percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid; it is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions. ( CSP )] (UMLS (CSP) C0002627) =Diagnostic Procedure ;
|
- 329. Aminoblastin
- (UMLS (NCI) C1510868) =Organic Chemical; Pharmacologic Substance
| - 379. Amniocentesis (consent & refusal)
- (UMLS (HL7) C1548812) =Health Care Activity =Consent Type;
|
- 330. aminobutyrate
- [aliphatic four carbon acids or their salts, substituted in any position with amino groups. ( CSP )] (UMLS (CSP) C0178474) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=aa;
=gamma aminobutyrate;
| - 380. AMNIOINFUSION
- [ ] (UMLS (ICD9CM) C0262671) =Therapeutic or Preventive Procedure ;
|
- 331. Aminochlorambucil
- (UMLS (NCI) C0607323) =Organic Chemical ;
| - 381. amnion
- [extraembryonic membrane which contains the embryo and amniotic fluid. ( CSP )] (UMLS (CSP) C0002630) =Embryonic Structure ;
|
- 332. aminocyclopentane carboxylate
- [ ] (UMLS (CSP) C0598256) =Amino Acid, Peptide, or Protein
| - 382. AMNION PROB NEC-ANTEPART
- [ ] (UMLS (ICD9CM) C0157161) =Disease or Syndrome
|
- 333. Aminoethylene
- [saturated, 3-membered organic ring system with 1 nitrogen heteroatom. ( CSP )] (UMLS (NCI) C0052794) =Organic Chemical ;
=nitrogenous heterocyclic compound;
=1,1',1"-phosphinothioylidynetrisaziridine | - 383. AMNION PROB NOS-ANTEPART
- [ ] (UMLS (ICD9CM) C0157165) =Disease or Syndrome
|
- 334. aminoformamidine
- [ ] (UMLS (CSP) C0598539) =Organic Chemical ;
| - 384. Amnionitis
- [Inflammation of the amnion. ( NCI )] (UMLS (NCI) C0002631) =Disease or Syndrome ;
|
- 335. Aminoformamidine Hydrochloride
- [The hydrochloride salt form of guanidine, a strong basic compound with parasympathomimetic activity. Guanidine hydrochloride enhances the release of acetylcholine following a nerve impulse and potentiates acetylcholine actions on muscarinic and nicotinic receptors. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes. (NCI05) ( NCI )] (UMLS (NCI) C0120447) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =Guanidine;
[AU300] PARASYMPATHOMIMETICS (CHOLINERGICS);
TO BE DELETED INGREDIENT PREPARATIONS;
=GUANIDINE HYDROCHLORIDE 125 MG;
| - 385. AMNIOSCOPY
- (UMLS (ICD9CM) C0002632) =Diagnostic Procedure ;
|
- 336. Aminoglutethimide/Hydrocortisone/Suramin
- (UMLS (NCI) C1510871) Suramin/AGT/HC;
=Therapeutic or Preventive Procedure ;
| - 386. AMNIOT EMBOL-DELIV W P/P
- [ ] (UMLS (ICD9CM) C0157549) =Disease or Syndrome
|
- 337. Aminoglycoside Agents
- [any of a group of antibiotics derived from various species of Streptomyces or produced synthetically; they inhibit protein synthesis by binding with the 30S ribosomal subunit. ( CSP )] (UMLS (NCI) C0003233) =Carbohydrate; Antibiotic
| - 387. AMNIOTC ASP W/O RESP SYM
- [ ] (UMLS (ICD9CM) C1561794) Aspiration of clear amniotic fluid without respiratory symptoms;
=Pathologic Function |
- 338. aminoguanidine
- [diamine oxidase and nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications. ( CSP )] (UMLS (CSP) C0282774) =Organic Chemical; Pharmacologic Substance ;
=Guanidines;
| - 388. AMNIOTIC ASP W RESP SYM
- [ ] (UMLS (ICD9CM) C1561796) Aspiration of clear amniotic fluid with respiratory symptoms;
=Pathologic Function |
- 339. aminohydrolase
- [ ] (UMLS (CSP) C0002559) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 389. Amniotic Cavity
- (UMLS (NCI) C0230976) =Body Space or Junction
|
- 340. aminolevulinate dehydratase
- [An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24. ( MSH )] (UMLS (CSP) C0002564) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 390. AMNIOTIC EMBOL-ANTEPART
- [ ] (UMLS (ICD9CM) C0157550) =Disease or Syndrome
|
- 341. aminopeptidase
- [A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11. ( MSH )] (UMLS (CSP) C0002570) =Amino Acid, Peptide, or Protein; Enzyme
| - 391. AMNIOTIC EMBOL-POSTPART
- [ ] (UMLS (ICD9CM) C0157551) =Disease or Syndrome
|
- 342. aminopeptidase N
- [Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide. ( MSH )] (UMLS (CSP) C0054943) =Amino Acid, Peptide, or Protein; Enzyme; Immunologic Factor
| - 392. AMNIOTIC EMBOLISM-DELIV
- [ ] (UMLS (ICD9CM) C0157548) =Acquired Abnormality
|
- 343. aminophosphonate
- [phosphonic acid, HPO(OH)2, or its salt, anion, or ester, with an amino group attached. ( CSP )] (UMLS (CSP) C0596079) =Inorganic Chemical ;
=phosphonate;
| - 393. AMNIOTIC EMBOLISM-UNSPEC
- [Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH. ( MSH )] (UMLS (ICD9CM) C0013927) =Disease or Syndrome =embolism;
Pregnancy Complications, Cardiovascular |
- 344. Aminophosphonate Metabolism
- (UMLS (NCI) C1510872) Aminophosphonate Metabolism Pathway;
=Molecular Function ;
| - 394. amniotic fluid
- [amniotic cavity fluid which is produced by the amnion and fetal lungs and kidneys. ( CSP )] (UMLS (CSP) C0002638) =Body Substance ;
|
- 345. Aminopterin Sodium
- (UMLS (NCI) C0282048) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 395. Amniotic fluid
- (UMLS (HL7) C1546538) =Intellectual Product =Specimen Source Codes;
|
- 346. Aminopterin/Leucovorin Calcium
- (UMLS (NCI) C0796626) APGA/CF =Therapeutic or Preventive Procedure
| - 396. Amniotic fluid
- (UMLS (HL7) C1610731) =Body Substance =SpecimenEntityType;
|
- 347. aminopyridine
- [pyridines substituted in any position with an amino group; may be hydrogenated, but must retain at least one double bond. ( CSP )] (UMLS (CSP) C0002585) =Organic Chemical ;
| - 397. AMNIOTIC INFECT-ANTEPART
- [ ] (UMLS (ICD9CM) C0157158) =Disease or Syndrome
|
- 348. aminopyrimidine
- [organic compound with a six-sided ring structure that includes two nitrogen atoms attached to an amino group. ( CSP )] (UMLS (CSP) C0596080) =Organic Chemical ;
=Pyrimidine;
=4-Amino-2(1H)-pyrimidinone;
DAP | - 398. AMNIOTIC INFECTION-DELIV
- [ ] (UMLS (ICD9CM) C0157157) =Disease or Syndrome
|
- 349. Aminosalicylate Sodium
- [The sodium salt form of aminosalicylic acid, an analog of para-aminobenzoic acid (PABA) with antitubercular activity. Aminosalicylate sodium exerts its bacteriostatic activity against Mycobacterium tuberculosis by competing with PABA for enzymes involved in folate synthesis, thereby suppressing growth and reproduction of M. tuberculosis, eventually leading to cell death. ( NCI )] (UMLS (NCI) C0301336) =Organic Chemical; Pharmacologic Substance =AMINOSALICYLATE;
=AMINOSALICYLATE SODIUM 1 GM;
AMINOSALICYLATE SODIUM 500 MG | - 399. AMNIOTIC PROB NEC-DELIV
- [ ] (UMLS (ICD9CM) C0157160) =Disease or Syndrome
|
- 350. Aminosidine Sulfate
- [The sulfate salt form of paromomycin, a structural derivative of neomycin, an aminoglycoside antibiotic with amebicidal and bactericidal effects against predominantly aerobic gram-negative bacteria. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation of mRNA and inhibition of protein synthesis followed by cell death. ( NCI )] (UMLS (NCI) C0205881) =Carbohydrate; Antibiotic =PAROMOMYCIN;
=PAROMOMYCIN SULFATE 250 MG;
| - 400. AMNIOTIC PROB NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0157159) =Disease or Syndrome
|
home
